BLOPRESS

This brand name is authorized in Austria, Brazil, Ecuador, Germany, Hong Kong SAR China, Ireland, Italy, Japan, Spain, Tunisia.

Active ingredients

The drug BLOPRESS contains one active pharmaceutical ingredient (API):

1	Candesartan cilexetil UNII R85M2X0D68 - CANDESARTAN CILEXETIL
	Candesartan is an AIIRA, selective for AT1 receptors, with tight binding to and slow dissociation from the receptor. It has no agonist activity. The antagonism of the angiotensin II (AT1) receptors results in dose related increases in plasma renin levels, angiotensin I and angiotensin II levels, and a decrease in plasma aldosterone concentration.
	Read more about Candesartan

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
BLOPRESS Tablet	MPI, EU: SmPC	Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C09CA06	Candesartan	C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09C Angiotensin II antagonists, plain → C09CA Angiotensin II antagonists, plain
Discover more medicines within C09CA06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	500200801114218, 500200803117214
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00394039, 00394080, 01137669, 01137712, 01510370, 01527672, 01527689, 01618067, 01998756, 02860362, 03420889, 03420895, 03420903, 04010188, 04142748, 04392221, 04392250, 04392267, 04392273, 04392296, 04392304, 04985027, 05992236, 07121103, 08625076, 08625082, 08625099, 08625113, 08625136, 08625142, 08625165, 08625171, 08625188, 09295043, 09295089, 10934229, 10962639, 10962645, 10962651, 10993060, 11046117, 11046146, 13233705, 14238171, 16749378, 17185297, 17275161
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	23.301-1-09-07, 23.304-1-09-07
ES	Centro de información online de medicamentos de la AEMPS	61995, 61996, 61997, 66439
HK	Department of Health Drug Office	44015, 44016
IE	Health Products Regulatory Authority	63900, 63901, 63902, 63903, 63904, 63905, 63906
IT	Agenzia del Farmaco	033451168, 033451269, 033451360, 039318023, 043896012, 044654010, 044804019, 044804021, 044804033
JP	医薬品医療機器総合機構	2149040F1026, 2149040F2022, 2149040F3029, 2149040F4025
TN	Direction de la Pharmacie et du Médicament	5063301, 5063302, 9073491, 9073492